Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient
Diagnostic and Interventional Cardiology,
Patient’s own tissue naturally turns synthetic polymer device into living heart valves and may reduce need for re-interventions…
Patient’s own tissue naturally turns synthetic polymer device into living heart valves and may reduce need for re-interventions…
Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that…
July 8, 2021 06:30 UTC Patient’s own tissue naturally turn device into living heart valves and may reduce need for re-interventio…
EINDHOVEN, the Netherlands